{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:11Z","timestamp":1790902451836,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\u03b1-synuclein is a pre-synaptic protein implicated in synucleinopathies including Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies, where it accumulates in intracellular aggregates termed Lewy bodies and Lewy neurites. Recent studies have reported that \u03b1-synuclein undergoes phase separation to form biomolecular condensates both in vitro and in mammalian cells. \u03b1-synuclein condensates are thought to contribute to disease through progressive aggregation. Here we show that specific PD-associated \u03b1-synuclein variants fail to form biomolecular condensates. We demonstrate that only two \u03b1-synuclein variants associated with disease, E46K and E83Q, enhance condensate formation. While other \u03b1-synuclein disease variants including A30G, G51D, and A53E fail to form condensates in cells. In iPSC-derived neurons, the extent of synaptic enrichment of different \u03b1-synuclein variants is linked to their propensity to undergo VAMP2-mediated phase separation. Our results emphasize that \u03b1-synuclein dysfunction may follow divergent pathways, with both increased and decreased condensate formation.<\/jats:p>","DOI":"10.1038\/s41467-026-77002-4","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:15:04Z","timestamp":1788344104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual effect of \u03b1-synuclein disease variants on condensate formation"],"prefix":"10.1038","volume":"17","author":[{"given":"Aswathy","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana R.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-7074","authenticated-orcid":false,"given":"Janin","family":"Lautenschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"77002_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. & Bloem, B. R. The parkinson pandemic\u2014a call to action. JAMA Neurol. 75, 9 (2018).","journal-title":"JAMA Neurol."},{"key":"77002_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"G. B. D. 2015 Neurological Disorders Collaborator Group.","year":"2017","unstructured":"G. B. D. 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 16, 877\u2013897 (2017).","journal-title":"Lancet Neurol."},{"key":"77002_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma, R. B. et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 33, 1601\u20131608 (2018).","journal-title":"Mov. Disord."},{"key":"77002_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"77002_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00401-020-02202-1","volume":"141","author":"J Br\u00e1s","year":"2021","unstructured":"Br\u00e1s, J., Gibbons, E. & Guerreiro, R. Genetics of synucleins in neurodegenerative diseases. Acta Neuropathol. 141, 471\u2013490 (2021).","journal-title":"Acta Neuropathol."},{"key":"77002_CR6","doi-asserted-by":"publisher","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019sdisease. Lancet Neurol. 19, 170\u2013178 https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X (2020).","DOI":"10.1016\/S1474-4422(19)30287-X"},{"key":"77002_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai, A. et al. The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467\u2013475 (1995).","journal-title":"Neuron"},{"key":"77002_CR8","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804\u20132815 (1988).","journal-title":"J. Neurosci."},{"key":"77002_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","volume":"27","author":"J Lautenschl\u00e4ger","year":"2017","unstructured":"Lautenschl\u00e4ger, J., Kaminski, C. F. & Kaminski Schierle, G. S. \u03b1-synuclein \u2013 regulator of exocytosis, endocytosis, or both? Trends Cell Biol. 27, 468\u2013479 (2017).","journal-title":"Trends Cell Biol."},{"key":"77002_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray, S. et al. \u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation. Nat. Chem. 12, 705\u2013716 (2020).","journal-title":"Nat. Chem."},{"key":"77002_CR11","doi-asserted-by":"publisher","unstructured":"Hardenberg, M. C. et al. Observation of an \u03b1-synuclein liquid droplet state and its maturation into Lewy body-like assemblies. J. Mol. Cell Biol.https:\/\/doi.org\/10.1093\/jmcb\/mjaa075 (2021).","DOI":"10.1093\/jmcb\/mjaa075"},{"key":"77002_CR12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41556-024-01451-6","volume":"26","author":"A Agarwal","year":"2024","unstructured":"Agarwal, A. et al. VAMP2 regulates phase separation of \u03b1-synuclein. Nat. Cell Biol. 26, 1296\u20131308 (2024).","journal-title":"Nat. Cell Biol."},{"key":"77002_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41556-024-01456-1","volume":"26","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. VAMP2 chaperones \u03b1-synuclein in synaptic vesicle co-condensates. Nat. Cell Biol. 26, 1287\u20131295 (2024).","journal-title":"Nat. Cell Biol."},{"key":"77002_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.tcb.2018.02.004","volume":"28","author":"S Boeynaems","year":"2018","unstructured":"Boeynaems, S. et al. Protein phase separation: a new phase in cell biology. Trends Cell Biol. 28, 420\u2013435 (2018).","journal-title":"Trends Cell Biol."},{"key":"77002_CR15","doi-asserted-by":"publisher","first-page":"167713","DOI":"10.1016\/j.jmb.2022.167713","volume":"435","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee, S. et al. Liquid-liquid phase separation of \u03b1-synuclein: a new mechanistic insight for \u03b1-synuclein aggregation associated with parkinson\u2019s disease pathogenesis. J. Mol. Biol. 435, 167713 (2023).","journal-title":"J. Mol. Biol."},{"key":"77002_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.devcel.2020.09.014","volume":"55","author":"A Zbinden","year":"2020","unstructured":"Zbinden, A., P\u00e9rez-Berlanga, M., De Rossi, P. & Polymenidou, M. Phase separation and neurodegenerative diseases: a disturbance in the force. Dev. Cell 55, 45\u201368 (2020).","journal-title":"Dev. Cell"},{"key":"77002_CR17","doi-asserted-by":"crossref","unstructured":"Kumar, S. T. et al. A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity. Sci. Adv. 8, eabn0044 (2022).","DOI":"10.1126\/sciadv.abn0044"},{"key":"77002_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s44319-025-00626-y","volume":"27","author":"K D\u00f6rner","year":"2025","unstructured":"D\u00f6rner, K. et al. Fluorescent protein and peptide tags alter condensate formation and dynamics in vivo and in vitro. EMBO Rep. 27, 89\u2013121 (2025).","journal-title":"EMBO Rep."},{"key":"77002_CR19","doi-asserted-by":"publisher","first-page":"137688","DOI":"10.1016\/j.ijbiomac.2024.137688","volume":"283","author":"M Ziaunys","year":"2024","unstructured":"Ziaunys, M. et al. Diverse effects of fluorescent labels on alpha-synuclein condensate formation during liquid-liquid phase separation. Int. J. Biol. Macromol. 283, 137688 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"77002_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","volume":"176","author":"S Alberti","year":"2019","unstructured":"Alberti, S., Gladfelter, A. & Mittag, T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell 176, 419\u2013434 (2019).","journal-title":"Cell"},{"key":"77002_CR21","doi-asserted-by":"publisher","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M600933200. (2006).","DOI":"10.1074\/jbc.M600933200"},{"key":"77002_CR22","doi-asserted-by":"publisher","unstructured":"Fujiwara, H. et al. \u03b1-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. https:\/\/doi.org\/10.1038\/ncb748. (2002).","DOI":"10.1038\/ncb748"},{"key":"77002_CR23","doi-asserted-by":"publisher","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033 (2011).","DOI":"10.1016\/j.neuron.2011.08.033"},{"key":"77002_CR24","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li, J., Uversky, V. N. & Fink, A. L. Effect of familial parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein. Biochemistry 40, 11604\u201311613 (2001).","journal-title":"Biochemistry"},{"key":"77002_CR25","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1021\/acs.biochem.8b00314","volume":"57","author":"GM Mohite","year":"2018","unstructured":"Mohite, G. M. et al. Comparison of kinetics, toxicity, oligomer formation, and membrane binding capacity of \u03b1-synuclein familial mutations at the A53 Site, including the newly discovered A53V mutation. Biochemistry 57, 5183\u20135187 (2018).","journal-title":"Biochemistry"},{"key":"77002_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16564-3","volume":"11","author":"AD Stephens","year":"2020","unstructured":"Stephens, A. D. et al. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity. Nat. Commun. 11, 2820 (2020).","journal-title":"Nat. Commun."},{"key":"77002_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","volume":"315","author":"E Jo","year":"2002","unstructured":"Jo, E., Fuller, N., Rand, R. P., St George-Hyslop, P. & Fraser, P. E. Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P \u03b1-synuclein. J. Mol. Biol. 315, 799\u2013807 (2002).","journal-title":"J. Mol. Biol"},{"key":"77002_CR28","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro, T. F. & Lindquist, S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772\u20131775 (2003).","journal-title":"Science"},{"key":"77002_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","volume":"9","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Rep. 9, 1221\u20131233 (2017).","journal-title":"Stem Cell Rep."},{"key":"77002_CR30","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1002\/cpcb.51","volume":"79","author":"MS Fernandopulle","year":"2018","unstructured":"Fernandopulle, M. S. et al. Transcription factor-mediated differentiation of human iPSCs into neurons. Curr. Protoc. Cell Biol. 79, e51 (2018).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"77002_CR31","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.neuron.2022.06.010","volume":"110","author":"Y Imoto","year":"2022","unstructured":"Imoto, Y. et al. Dynamin is primed at endocytic sites for ultrafast endocytosis. Neuron 110, 2815\u20132835.e13 (2022).","journal-title":"Neuron"},{"key":"77002_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106826","volume":"26","author":"T Yoshida","year":"2023","unstructured":"Yoshida, T. et al. Compartmentalization of soluble endocytic proteins in synaptic vesicle clusters by phase separation. iScience 26, 106826 (2023).","journal-title":"iScience"},{"key":"77002_CR33","doi-asserted-by":"crossref","unstructured":"Xu, B. et al. Distinct effects of familial parkinson\u2019s disease-associated mutations on \u03b1-synuclein phase separation and amyloid aggregation. Biomolecules 13, 726 (2023).","DOI":"10.3390\/biom13050726"},{"key":"77002_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/neup.12687","volume":"40","author":"A Kapasi","year":"2020","unstructured":"Kapasi, A. et al. A novel SNCA E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration. Neuropathology 40, 620\u2013626 (2020).","journal-title":"Neuropathology"},{"key":"77002_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318\u20131320 (1998).","journal-title":"Nat. Med."},{"key":"77002_CR36","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas, L. A. et al. Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111, 4006\u20134023.e10 (2023).","journal-title":"Neuron"},{"key":"77002_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam, N. et al. Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 9, 4 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"77002_CR38","doi-asserted-by":"crossref","unstructured":"Ramalingam, N., Brontesi, L., Jin, S., Selkoe, D. J. & Dettmer, U. Dynamic reversibility of \u03b1-synuclein serine-129 phosphorylation is impaired in synucleinopathy models. EMBO Rep. 24, e57145 (2023).","DOI":"10.15252\/embr.202357145"},{"key":"77002_CR39","doi-asserted-by":"crossref","unstructured":"Ray, S. et al. Divergent effects of pathological \u03b1-synuclein truncations and mutations on phase separation. Nat. Commun. 17, 7987 (2026).","DOI":"10.1038\/s41467-026-74627-3"},{"key":"77002_CR40","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton, E. R. & Rhoades, E. Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles. Biophys. J. 99, 2279\u20132288 (2010).","journal-title":"Biophys. J."},{"key":"77002_CR41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/bi901723p","volume":"49","author":"CR Bodner","year":"2010","unstructured":"Bodner, C. R., Maltsev, A. S., Dobson, C. M. & Bax, A. Differential phospholipid binding of \u03b1-synuclein variants implicated in parkinson\u2019s disease revealed by solution NMR spectroscopy. Biochemistry 49, 862\u2013871 (2010).","journal-title":"Biochemistry"},{"key":"77002_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.molcel.2018.12.007","volume":"73","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. RIM and RIM-BP form presynaptic active-zone-like condensates via phase separation. Mol. Cell 73, 971\u2013984.e5 (2019).","journal-title":"Mol. Cell"},{"key":"77002_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41556-022-00882-3","volume":"24","author":"WT Snead","year":"2022","unstructured":"Snead, W. T. et al. Membrane surfaces regulate assembly of ribonucleoprotein condensates. Nat. Cell Biol. 24, 461\u2013470 (2022).","journal-title":"Nat. Cell Biol."},{"key":"77002_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.molcel.2022.02.035","volume":"82","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Lipid-mediated phase separation of AGO proteins on the ER controls nascent-peptide ubiquitination. Mol. Cell 82, 1313\u20131328.e8 (2022).","journal-title":"Mol. Cell"},{"key":"77002_CR45","doi-asserted-by":"publisher","unstructured":"Mangiarotti, A. & Dimova, R. Phase separation across membranes and condensates in cell organization and function. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-026-00961-5 (2026).","DOI":"10.1038\/s41580-026-00961-5"},{"key":"77002_CR46","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","volume":"23","author":"M-B Fares","year":"2014","unstructured":"Fares, M.-B. et al. The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of a-synuclein, and enhances its secretion and nuclear localization in cells. Hum. Mol. Genet. 23, 4491\u20134509 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"77002_CR47","doi-asserted-by":"publisher","unstructured":"Ysselstein, D. et al. Effects of impaired membrane interactions on \u03b1-synuclein aggregation and neurotoxicity. Neurobiol. Dis. https:\/\/doi.org\/10.1016\/j.nbd.2015.04.007 (2015).","DOI":"10.1016\/j.nbd.2015.04.007"},{"key":"77002_CR48","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh, D. et al. The newly discovered parkinson\u2019s disease associated finnish mutation (A53E) attenuates \u03b1-synuclein aggregation and membrane binding. Biochemistry 53, 6419\u20136421 (2014).","journal-title":"Biochemistry"},{"key":"77002_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20462-z","volume":"12","author":"D Park","year":"2021","unstructured":"Park, D. et al. Cooperative function of synaptophysin and synapsin in the generation of synaptic vesicle-like clusters in non-neuronal cells. Nat. Commun. 12, 263 (2021).","journal-title":"Nat. Commun."},{"key":"77002_CR50","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin, D. L. et al. Lipid rafts mediate the synaptic localization of \u03b1-synuclein.  J. Neurosci. 24, 6715\u20136723 (2004).","journal-title":"J. Neurosci."},{"key":"77002_CR51","doi-asserted-by":"publisher","first-page":"fcaf224","DOI":"10.1093\/braincomms\/fcaf224","volume":"7","author":"S West","year":"2025","unstructured":"West, S. et al. Glycine-to-aspartic acid mutation at codon 51 in Snca disrupts the synaptic localisation of \u03b1-synuclein and enhances its propensity for synucleinopathy. Brain Commun. 7, fcaf224 (2025).","journal-title":"Brain Commun."},{"key":"77002_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg5663","volume":"9","author":"L Piroska","year":"2023","unstructured":"Piroska, L. et al. \u03b1-Synuclein liquid condensates fuel fibrillar \u03b1-synuclein growth. Sci. Adv. 9, eadg5663 (2023).","journal-title":"Sci. Adv."},{"key":"77002_CR53","first-page":"1440","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science (1979) 358, 1440\u20131443 (2017).","journal-title":"Science (1979)"},{"key":"77002_CR54","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1021\/acs.biochem.8b00321","volume":"57","author":"GM Mohite","year":"2018","unstructured":"Mohite, G. M. et al. The familial \u03b1-synuclein A53E mutation enhances cell death in response to environmental toxins due to a larger population of oligomers. Biochemistry 57, 5014\u20135028 (2018).","journal-title":"Biochemistry"},{"key":"77002_CR55","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1021\/bi501369k","volume":"54","author":"AND Stefanovic","year":"2015","unstructured":"Stefanovic, A. N. D., Lindhoud, S., Semerdzhiev, S. A., Claessens, M. M. A. E. & Subramaniam, V. Oligomers of Parkinson\u2019s disease-related \u03b1-synuclein mutants have similar structures but distinctive membrane permeabilization properties. Biochemistry 54, 3142\u20133150 (2015).","journal-title":"Biochemistry"},{"key":"77002_CR56","doi-asserted-by":"publisher","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: Implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.97.2.571 (2000).","DOI":"10.1073\/pnas.97.2.571"},{"key":"77002_CR57","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/molecules27041293","volume":"27","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity. Molecules 27, 1293 (2022).","journal-title":"Molecules"},{"key":"77002_CR58","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1212\/NXG.0000000000000027","volume":"1","author":"MH Martikainen","year":"2015","unstructured":"Martikainen, M. H., P\u00e4iv\u00e4rinta, M., Hietala, M. & Kaasinen, V. Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation. Neurol. Genet. 1, e27 (2015).","journal-title":"Neurol. Genet."},{"key":"77002_CR59","doi-asserted-by":"publisher","first-page":"168.e5","DOI":"10.1016\/j.neurobiolaging.2016.10.014","volume":"50","author":"P Pasanen","year":"2017","unstructured":"Pasanen, P. et al. SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish population. Neurobiol. Aging 50, 168.e5\u2013168.e8 (2017).","journal-title":"Neurobiol. Aging"},{"key":"77002_CR60","doi-asserted-by":"publisher","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen, P. et al. Novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol. Aging 35, 2180.e1\u20135 (2014).","journal-title":"Neurobiol. Aging"},{"key":"77002_CR61","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely, A. P. et al. \u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol. 125, 753\u2013769 (2013).","journal-title":"Acta Neuropathol."},{"key":"77002_CR62","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage, S. et al. G51D \u03b1-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459\u2013471 (2013).","journal-title":"Ann. Neurol."},{"key":"77002_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.parkreldis.2013.11.008","volume":"20","author":"T Tokutake","year":"2014","unstructured":"Tokutake, T. et al. Clinical and neuroimaging features of patient with early-onset Parkinson\u2019s disease with dementia carrying SNCA p.G51D mutation. Parkinsonism Relat. Disord. 20, 262\u2013264 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"77002_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2016.12.032","volume":"168","author":"SC Phua","year":"2017","unstructured":"Phua, S. C. et al. Dynamic remodeling of membrane composition drives cell cycle through primary cilia excision. Cell 168, 264\u2013279.e15 (2017).","journal-title":"Cell"},{"key":"77002_CR65","doi-asserted-by":"publisher","unstructured":"Chertkova, A. O. et al. Robust and Bright Genetically Encoded Fluorescent Markers for Highlighting Structures and Compartments in Mammalian Cells. bioRXIV Preprint at https:\/\/doi.org\/10.1101\/160374 (2020).","DOI":"10.1101\/160374"},{"key":"77002_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nmeth.1437","volume":"7","author":"SB Van Engelenburg","year":"2010","unstructured":"Van Engelenburg, S. B. & Palmer, A. E. Imaging type-III secretion reveals dynamics and spatial segregation of Salmonella effectors. Nat. Methods 7, 325\u2013330 (2010).","journal-title":"Nat. Methods"},{"key":"77002_CR67","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1073\/pnas.082243699","volume":"99","author":"RE Campbell","year":"2002","unstructured":"Campbell, R. E. et al. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 99, 7877\u20137882 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77002_CR68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nmeth.4074","volume":"14","author":"DS Bindels","year":"2017","unstructured":"Bindels, D. S. et al. mScarlet: a bright monomeric red fluorescent protein for cellular imaging. Nat. Methods 14, 53\u201356 (2017).","journal-title":"Nat. Methods"},{"key":"77002_CR69","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"77002_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21027-4","volume":"12","author":"WK Man","year":"2021","unstructured":"Man, W. K. et al. The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition. Nat. Commun. 12, 927 (2021).","journal-title":"Nat. Commun."},{"key":"77002_CR71","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1016\/j.cell.2021.09.021","volume":"184","author":"AJ Modzelewski","year":"2021","unstructured":"Modzelewski, A. J. et al. A mouse-specific retrotransposon drives a conserved Cdk2ap1 isoform essential for development. Cell 184, 5541\u20135558.e22 (2021).","journal-title":"Cell"},{"key":"77002_CR72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bpj.2013.05.024","volume":"105","author":"A Weinberger","year":"2013","unstructured":"Weinberger, A. et al. Gel-assisted formation of giant unilamellar vesicles. Biophys. J. 105, 154\u2013164 (2013).","journal-title":"Biophys. J."},{"key":"77002_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2007.13","volume":"2","author":"RD Gietz","year":"2007","unstructured":"Gietz, R. D. & Schiestl, R. H. High-efficiency yeast transformation using the LiAc\/SS carrier DNA\/PEG method. Nat. Protoc. 2, 31\u201334 (2007).","journal-title":"Nat. Protoc."},{"key":"77002_CR74","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"J-P Concordet","year":"2018","unstructured":"Concordet, J.-P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res 46, W242\u2013W245 (2018).","journal-title":"Nucleic Acids Res"},{"key":"77002_CR75","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"77002_CR76","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41592-021-01126-2","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nat. Methods 18, 528\u2013541 (2021).","journal-title":"Nat. Methods"},{"key":"77002_CR77","doi-asserted-by":"crossref","unstructured":"Nixon-Abell, J. et al. Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER. Science 354, aaf3928 (2016).","DOI":"10.1126\/science.aaf3928"},{"key":"77002_CR78","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"77002_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36081-3","volume":"14","author":"D Park","year":"2023","unstructured":"Park, D. et al. Synaptic vesicle proteins and ATG9A self-organize in distinct vesicle phases within synapsin condensates. Nat. Commun. 14, 455 (2023).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77002-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:01Z","timestamp":1790899441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77002"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77002-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10442"}}